Jeff Yass’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
Jeff Yass's NPCE Position: Q3 2026 in Review
Jeff Yass sold out of Neuropace (NPCE) in Q3 2026, closing a stake of 10,154 shares — an estimated $161K sold.
Jeff Yass first reported a position in NPCE in Q1 2023 and held it in 9 quarters. The position peaked at $2.69M in Q1 2024. 105 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.
- Jeff Yass reported no remaining Neuropace position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 10,154 Neuropace shares in Q3 2026, an estimated $161K.
- Jeff Yass first reported a position in Neuropace in Q1 2023 and held it in 9 quarters.
- Jeff Yass's Neuropace position peaked at $2.69M in Q1 2024.
- 105 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.